*Refresh the page if the below document does not appear.
On Friday, the Government constituted an expert panel to prepare a “National Drugs Database” which will be a comprehensive database of drugs manufactured and marketed in the country. This will help in monitoring their quality and regulatory policies associated with them.
Lupin Limited declared that they have received tentative approval from US FDA for its ANDA (Abbreviated New Drug Application) for Drospirenone tablets (4 mg strength). Drospirenone tablets are the generic equivalent of Slynd Tablets (4 mg) of Exeltis USA.
Indian Pharma industry is looking forward to greater market access in the UK as part of the proposed free trade agreement with Britain. The official stated that both countries are trying to sign a deal that works for their national interests.
Indian drugmaker Cipla Limited showed a greater than estimated, 11% rise in the second quarter profit on Friday which was backed by a high demand for its drugs, inhalers, and a boost in its new ventures.
Sanofi and AstraZeneca Plc’s Beyfortus received European approval to use it on infants before their first RSV season. The antibody injection will protect infants by the age of two from the common virus that might turn deadly otherwise.
In Friday’s update of BSE’s (Bombay Stock Exchange) “A” group, since Ajanta Pharma Limited lost 6.65% to Rs 1258.55 at 14:45, its stock was shown to be the biggest loser in the group.
India’s Msc Agency Private Limited is a
worldwide shipping Agency with 675 local
offices and over 1000 refer experts. It said in
a report that it is GDP (Good Distribution
Practices) compliant and provides reliable
and cost-effective deliveries to any
If you don’t already have an account click the button below to create your account.Create New Account